Skip to main content
Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
1.210
+0.020 (1.68%)
At close: Apr 28, 2026, 4:00 PM EDT
1.200
-0.010 (-0.83%)
Pre-market: Apr 29, 2026, 5:31 AM EDT

Heron Therapeutics Revenue

In the year 2025, Heron Therapeutics had annual revenue of $154.90M with 7.36% growth. Heron Therapeutics had revenue of $40.59M in the quarter ending December 31, 2025, a decrease of -0.47%.

Revenue (ttm)
$154.90M
Revenue Growth
+7.36%
P/S Ratio
1.47
Revenue / Employee
$1,210,188
Employees
128
Market Cap
228.25M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025154.90M10.62M7.36%
Dec 31, 2024144.29M17.24M13.57%
Dec 31, 2023127.04M19.37M17.99%
Dec 31, 2022107.67M21.33M24.70%
Dec 31, 202186.35M-2.29M-2.59%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Keros Therapeutics 244.06M
Arcturus Therapeutics Holdings 82.03M
Fennec Pharmaceuticals 44.64M
Voyager Therapeutics 40.37M
Adagene 7.67M
Camp4 Therapeutics 3.50M
Milestone Pharmaceuticals 1.55M
Revenue Rankings

HRTX News

More News